MENOGENIX

menogenix-logo

MenoGeniX, Inc., a clinical stage biotechnology company, focuses on the development of drugs for menopause and the menopause-like symptoms that occur in breast and prostate cancer patients. The company was founded in 2010 and is based in Aurora, Colorado.

#SimilarOrganizations #People #Financial #Website #More

MENOGENIX

Industry:
Biotechnology Medical Medical Device

Founded:
2010-01-01

Address:
Aurora, Colorado, United States

Country:
United States

Website Url:
http://www.menogenix.com

Total Employee:
1+

Status:
Active

Contact:
+720-859-4080

Email Addresses:
info@menogenix.com

Total Funding:
1.11 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Content Delivery Network Euro Typekit Squarespace Squarespace Add To Cart


Similar Organizations

dauntless-pharmaceuticals-logo

Dauntless Pharmaceuticals

Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

pharmacyte-biotech-logo

PharmaCyte Biotech

PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer.

phloronol-logo

Phloronol

Phloronol, a biotechnology company, explicates anti-oxidant metabolic benefits of polyphenols/phlorotannins, extracted from marine algae.

Current Employees Featured

debra-m-duke_image

Debra M. Duke
Debra M. Duke Founder, President, and CEO @ MenoGeniX
Founder, President, and CEO
2010-01-01

douglas-farrar_image

Douglas Farrar
Douglas Farrar Co-Founder @ MenoGeniX
Co-Founder

richard-c-duke_image

Richard C. Duke
Richard C. Duke Chairman @ MenoGeniX
Chairman
2010-06-01

woodruff-emlen_image

Woodruff Emlen
Woodruff Emlen Director, Acting Chief Medical Officer @ MenoGeniX
Director, Acting Chief Medical Officer

Founder


debra-m-duke_image

Debra M. Duke

douglas-farrar_image

Douglas Farrar

Investors List

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - MenoGeniX

Official Site Inspections

http://www.menogenix.com

  • Host name: 198.185.159.145
  • IP address: 198.185.159.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "MenoGeniX"

MenoGeniX

MenoGeniX is a privately-held, clinical stage biopharmaceutical company, dedicated to researching and developing a novel potential treatment for women suffering from hot flashes …See details»

About MenoGeniX

MenoGeniX is a clinical-stage biotech company dedicated to women’s health focused on developing a novel potential treatment for women suffering from hot flashes and related vasomotor symptoms of menopause.See details»

Management & Business Advisors — MenoGeniX

Debra Duke is the president of MenoGeniX, which she co-founded in 2010. She has 30 years of business experience in the biotechnology and energy industries.See details»

MenoGeniX - Crunchbase Company Profile & Funding

MenoGeniX, Inc., a clinical stage biotechnology company, focuses on the development of drugs for menopause and the menopause-like symptoms that occur in breast and prostate cancer patients. The company was founded in …See details»

MenoGeniX Company Profile 2024: Valuation, Funding & Investors …

Developer of drugs designed to help women treat menopausal problems. The company's drugs treat hot flashes and related vasomotor symptoms of menopause and it offers hormone …See details»

Startup aims to cool hot flashes - UCHealth Today

Jan 24, 2017 Â· Debra Duke founded MenoGeniX to bring a drug the FDA originally approved in 1991 to market — this time to help women deal with menopausal hot flashes. Hot flashes are uncomfortable, they’re disruptive, …See details»

MenoGeniX, Inc - LinkedIn

MenoGeniX is a privately-held, clinical stage biopharmaceutical company, dedicated to researching and developing a novel potential treatment for women suffering from hot flashes …See details»

MenoGeniX - Org Chart, Teams, Culture & Jobs - The Org

View MenoGeniX's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

MenoGeniX - Contacts, Employees, Board Members, Advisors

MenoGeniX is a clinical stage biotechnology company focusing on the development of drugs for menopause.See details»

MenoGeniX - Funding, Financials, Valuation & Investors

MenoGeniX is a clinical stage biotechnology company focusing on the development of drugs for menopause.See details»

MenoGeniX - Overview, News & Similar companies | ZoomInfo.com

MenoGeniX. Manufacturing · Colorado, United States · <25 Employees. MenoGeniX is a clinical-stage biotech company dedicated to womens health focused on developing a novel potential …See details»

MENOGENIX, INC. Company Profile | Aurora, CO - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for MENOGENIX, INC. of Aurora, CO. Get the latest business insights from Dun & Bradstreet.See details»

Clinical Trials - MenoGeniX

MenoGeniX has completed a multicenter, double-blind, randomized, placebo-controlled Phase I clinical trial that evaluated the safety and effectiveness of MNGX-100 in treating hot flashes in …See details»

MenoGeniX Company Profile - Office Locations, Competitors

MenoGeniX is a clinical-stage biopharmaceutical company. It researches and develops a potential treatment for women suffering from hot flashes and related vasomotor symptoms of …See details»

MenoGeniX Inc. - insights.citeline.com

Apr 16, 2015 Â· MenoGeniX is developing a repurposed form of filgrastim as a non-hormonal treatment for menopausal symptoms, including hot flashes. Having achieved clinically …See details»

NK3R antagonists: a novel approach for menopause symptoms

Sep 1, 2023 Â· Now, studies have demonstrated that neurokinin 3 receptor antagonists have a level of effectiveness against vasomotor symptoms that is similar to that of hormone therapy. …See details»

Gladys Monroy - Business Advisor at MenoGeniX - The Org

MenoGeniX. Gladys Monroy; Gladys Monroy. Business Advisor at MenoGeniX. Contact. Dr. Gladys Monroy is a patent attorney specializing in the life sciences and has practiced patent …See details»

Contact — MenoGeniX

12635 East Montview Blvd. Suite 100 Aurora, Colorado, USA 80045 info@menogenix.comSee details»

Abortion pill access requests surge from U.S., Canadian non-profit …

1 day ago Â· The Canadian non-profit organization provides online consultation and medication for women around the world seeking abortion says it has seen a fourfold increase in U.S. …See details»

Scientific Advisors - MenoGeniX

Collaborative projects with other investigators at the University of Colorado Health Sciences Center (UCDHSC) include the role of sex hormones in body weight distribution at menopause …See details»

linkstock.net © 2022. All rights reserved